Gansu Constar pitches private label contact lenses with dual FDA, CE certifications

Gansu Constar Technology Group says its Constar contact lens portfolio is helping beauty brands and distributors launch private label products faster across global markets. The company is leaning on dual FDA and CE certifications, broad design capacity and OEM/ODM services as demand grows for colored and specialty lenses. Why it matters: - Private label brands in colored and specialty contact lenses can cut manufacturing costs and speed up launches by outsourcing production. - Gansu Constar Technology Group is positioning its Constar portfolio as a compliance-first option for brands entering the U.S., Europe, Australia and Southeast Asia. - The company says its regulatory profile and production scale help reduce risk for retailers, distributors and beauty brands. What happened: - Gansu Constar Technology Group unveiled its Constar contact lens portfolio as a private label manufacturing solution for beauty brands, distributors and retailers. - The company says the portfolio includes FDA and CE dual-certified lenses. - The release was dated June 15, 2026, and identified Baiyin, Gansu, China, as the company’s base. The details: - Gansu Constar says the Constar lineup includes more than 4,000 designs across natural, sparkle, gradient and theatrical cosplay series. - The company says it holds both FDA and CE certifications, along with ISO 13485 and regional approvals including TGA, AKL and SFDA. - Gansu Constar says it is the only Chinese manufacturer with both FDA and CE certifications simultaneously. - The company operates six production facilities across Gansu and Hunan provinces. - Gansu Constar says monthly output reaches 15 million lenses. - The in-house design studio develops more than 1,000 new patterns each month. - Product features include high-oxygen silicone hydrogel options, sandwich printing technology, UV protection and custom parameter flexibility. - Private label terms include a low minimum order quantity starting at 1,000 pieces. - The company says physical samples are available in about 10 days. - Gansu Constar offers OEM and ODM services, including custom molds, exclusive patterns and branded packaging. - The company also offers care products such as multi-purpose solutions, eye washes and starter kits. - Gansu Constar says brands can move from initial brief to shipment in as little as 55 days. Between the lines: - The release frames regulation as a competitive advantage, not just a compliance requirement. - The pitch targets brands that want fashion-driven differentiation without building their own factories. - The emphasis on documentation, sampling speed and bundled care products suggests Gansu Constar is selling a turnkey private label program, not just lenses. - Gansu Constar says it allocates around 10% of revenue annually to R&D, signaling continued investment in materials, design and compliance. What’s next: - Gansu Constar is likely to keep pushing private label expansion as demand rises for personalized and trend-driven eyewear. - The company says its R&D spending will support future material science, design innovation and regulatory work. - Interested buyers can review the full product range , manufacturing capabilities , FDA and CE certified solutions , in-stock and custom options and OEM/ODM inquiries . The bottom line: - Gansu Constar is betting that compliance, speed and customization will win private label business in the fast-growing contact lens market.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Investor News Updates

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Investor News Updates

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.